MSD rotavirus vaccine approved to launch market

Published: 2007-06-27 06:57:00

Updated: 2007-06-27 06:57:00

The KFDA approved Rotateq for the prevention of infant's viral infections in the gastrointestinal tracts by G1, G2, G3, G4, G9PIA (8) types of rotavirus.

The market distribution of Rotateq and customers services will be responsible by SK Chemical according to the strategic alliance between MSD Korea and SK Chemical signed in earlier April this year.

President Maag Timney of MSD Korea...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.